World Journal of Urology

, Volume 31, Issue 6, pp 1463–1468 | Cite as

Clinical features of supervoiders who suffer from lower urinary tract symptoms: a propensity score-matching study

  • Joo Yong Lee
  • Yoon Soo Hah
  • Dae Hun Lee
  • Woo Jin Bang
  • Won Sik Ham
  • Seung Wook Lee
  • Kang Su Cho
Original Article

Abstract

Purpose

To evaluate the clinical characteristics of patients with maximal urine flow rate (Q max) ≥ 25 ml/s complaining of lower urinary tract symptoms (LUTS), using propensity score-matching analysis to compare with the control group.

Methods

Medical records from a prospectively maintained database for first visit male patients with LUTS/benign prostatic hyperplasia between 2010 and 2012 were used to select 818 patients. Of these patients, 68 men with Q max ≥ 25 ml/s were defined as the supervoider group, and 68 patients were selected for the control group using propensity scores, which were calculated for each patient using multivariable logistic regression model based on the following covariates: age, prostate volume, voided urine volume, and post-voided residual volume. International Prostate Symptom Score (IPSS), quality of life score, and Overactive Bladder Symptom Score (OABSS) were also analyzed.

Results

Mean Q max was 30.82 ± 5.13 in supervoiders and 15.95 ± 4.88 ml/s in controls (p < 0.001). There were statistical differences in IPSS between supervoiders and controls (12.63 ± 5.81 vs. 16.13 ± 6.90; p = 0.002). Although the IPSS voiding symptom sub-score in supervoiders was lower than controls (5.09 ± 3.35 vs. 7.40 ± 4.00; p < 0.001), there were no significant differences in storage symptom and post-micturitional symptom sub-scores. In OABSS and subdomain scores for frequency, nocturia, and urgency, there were no significant differences between the groups. However, the urge incontinence subdomain score was significantly higher in supervoiders versus controls (0.69 ± 1.26 vs. 0.18 ± 0.52; p = 0.003).

Conclusions

Supervoiders experience comparable levels of storage and post-micturition symptoms, but display more severe urge incontinence despite milder voiding symptoms and better uroflowmetric measurements than propensity score-matched controls.

Keywords

Lower urinary tract symptoms Urinary bladder Overactive Urinary incontinence Urge 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49PubMedCrossRefGoogle Scholar
  2. 2.
    Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274PubMedCrossRefGoogle Scholar
  3. 3.
    Ko DS, Fenster HN, Chambers K, Sullivan LD, Jens M, Goldenberg SL (1995) The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia. J Urol 154:396–398PubMedCrossRefGoogle Scholar
  4. 4.
    Ezz el Din K, Kiemeney LA, de Wildt MJ, Debruyne FM, de la Rosette JJ (1996) Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology 48:393–397PubMedCrossRefGoogle Scholar
  5. 5.
    Tanagho EA, Deng DY (2008) Urodynamic studies. In: Tanagho EA, Jack WM (eds) Smith's general urology, 17th edn. The McGraw-Hill companies, New York, NY, USAGoogle Scholar
  6. 6.
    Akikwala TV, Fleischman N, Nitti VW (2006) Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol 176:2093–2097PubMedCrossRefGoogle Scholar
  7. 7.
    Parsons KF, O’Boyle PJ, Gibbon NO (1977) A further assessment of bladder transection in the management of adult enuresis and allied conditions. Br J Urol 49:509–514PubMedCrossRefGoogle Scholar
  8. 8.
    Homma Y, Yoshida M, Obara K, Seki N, Yamaguchi O (2005) Development and validity of the Overactive Bladder Symptom Score (OABSS). Jpn J Urol 96:182Google Scholar
  9. 9.
    Jeong SJ, Homma Y, Oh SJ (2011) Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation. Int Neurourol J 15:135–142PubMedCrossRefGoogle Scholar
  10. 10.
    Lee HH, Lee JY, Yu HS, Diaz RR, Ham WS, Rha KH, Choi YD, Cho KS (2013) Impact of bent distortion on accuracy of measurement during transrectal ultrasonography for prostatic imaging: a preliminary study. Urology 81:915–919Google Scholar
  11. 11.
    Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712–716PubMedCrossRefGoogle Scholar
  12. 12.
    Rubin DB, Thomas N (1996) Matching using estimated propensity scores: relating theory to practice. Biometrics 52:249–264PubMedCrossRefGoogle Scholar
  13. 13.
    Rubin DB (2004) On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13:855–857PubMedCrossRefGoogle Scholar
  14. 14.
    Austin PC (2008) A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 27:2037–2049PubMedCrossRefGoogle Scholar
  15. 15.
    Djavan B (2003) Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient’s quality of life. Urology 62:6–14PubMedCrossRefGoogle Scholar
  16. 16.
    Rosenberg MT, Staskin DR, Kaplan SA, MacDiarmid SA, Newman DK, Ohl DA (2007) A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract 61:1535–1546PubMedCrossRefGoogle Scholar
  17. 17.
    Yamaguchi O, Aikawa K, Shishido K, Nomiya M (2009) Place of overactive bladder in male lower urinary tract symptoms. World J Urol 27:723–728PubMedCrossRefGoogle Scholar
  18. 18.
    Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150:351–358PubMedGoogle Scholar
  19. 19.
    Hyman MJ, Groutz A, Blaivas JG (2001) Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol 166:550–552 discussion 553PubMedCrossRefGoogle Scholar
  20. 20.
    Jorgensen JB, Jensen KM (1996) Uroflowmetry. Urol Clin North Am 23:237–242PubMedCrossRefGoogle Scholar
  21. 21.
    Jepsen JV, Bruskewitz RC (1998) Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 51:13–18PubMedCrossRefGoogle Scholar
  22. 22.
    Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, Lieber MM (1995) Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 153:1510–1515PubMedCrossRefGoogle Scholar
  23. 23.
    Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178PubMedCrossRefGoogle Scholar
  24. 24.
    Romanzi LJ, Groutz A, Heritz DM, Blaivas JG (2001) Involuntary detrusor contractions: correlation of urodynamic data to clinical categories. Neurourol Urodyn 20:249–257PubMedCrossRefGoogle Scholar
  25. 25.
    DuBeau CE, Levy B, Mangione CM, Resnick NM (1998) The impact of urge urinary incontinence on quality of life: importance of patients’ perspective and explanatory style. J Am Geriatr Soc 46:683–692PubMedGoogle Scholar
  26. 26.
    Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, Yamanishi T, Homma Y, Takeda M, Araki I, Obara K, Nishizawa O, Igawa Y, Goto M, Yokoyama O, Seki N, Takei M, Yoshida M (2007) Defining overactive bladder as hypersensitivity. Neurourol Urodyn 26:904–907PubMedCrossRefGoogle Scholar
  27. 27.
    Lee SR, Kim HJ, Kim A, Kim JH (2010) Overactive bladder is not only overactive but also hypersensitive. Urology 75:1053–1059PubMedCrossRefGoogle Scholar
  28. 28.
    Takeda M, Araki I, Kamiyama M, Takihana Y, Komuro M, Furuya Y (2003) Diagnosis and treatment of voiding symptoms. Urology 62:11–19PubMedCrossRefGoogle Scholar
  29. 29.
    Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V (2004) Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf 13:841–853PubMedCrossRefGoogle Scholar
  30. 30.
    D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Joo Yong Lee
    • 1
  • Yoon Soo Hah
    • 1
  • Dae Hun Lee
    • 1
  • Woo Jin Bang
    • 2
  • Won Sik Ham
    • 1
  • Seung Wook Lee
    • 3
  • Kang Su Cho
    • 1
  1. 1.Department of Urology, Severance Hospital, Urological Science InstituteYonsei University College of MedicineSeoulKorea
  2. 2.Department of UrologyHallym University College of MedicineChuncheonKorea
  3. 3.Department of UrologyHanyang University College of MedicineSeoulKorea

Personalised recommendations